G
Gianpiero D'Offizi
Researcher at Sapienza University of Rome
Publications - 140
Citations - 3182
Gianpiero D'Offizi is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Viral load & Hepatitis C. The author has an hindex of 28, co-authored 140 publications receiving 2624 citations.
Papers
More filters
Journal ArticleDOI
Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
Laura Falasca,Roberta Nardacci,Daniele Colombo,Eleonora Lalle,Antonino Di Caro,Emanuele Nicastri,Andrea Antinori,Nicola Petrosillo,Luisa Marchioni,Gianluigi Biava,Gianpiero D'Offizi,Fabrizio Palmieri,Delia Goletti,Alimuddin Zumla,Alimuddin Zumla,Giuseppe Ippolito,Mauro Piacentini,Franca Del Nonno +17 more
TL;DR: SARS-CoV-2 infection causes multisystem disease and significant pathology in most organs in patients with and without comorbidities.
Journal ArticleDOI
National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management.
Emanuele Nicastri,Nicola Petrosillo,Tommaso Ascoli Bartoli,Luciana Lepore,Annalisa Mondi,Fabrizio Palmieri,Gianpiero D'Offizi,Luisa Marchioni,Silvia Murachelli,Giuseppe Ippolito,Andrea Antinori +10 more
TL;DR: Recommendations for the management of COVID-19 patients are shown, based on very limited clinical evidences, which should be considered as expert opinions, which may be modified according to newly produced literature data.
Journal ArticleDOI
Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations.
Gabriella Rozera,Isabella Abbate,Alessandro Bruselles,Crhysoula Vlassi,Gianpiero D'Offizi,Pasquale Narciso,Giovanni Chillemi,Mattia Prosperi,Giuseppe Ippolito,Maria Rosaria Capobianchi +9 more
TL;DR: This study provided the first direct comparison between the HIV-1 quasispecies archived as provirus in circulating monocytes and T lymphocytes with that of plasma virions replicating in the same cell types.
Journal ArticleDOI
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
Adriano M. Pellicelli,Marzia Montalbano,Raffaella Lionetti,Christine M. Durand,Peter Ferenci,Gianpiero D'Offizi,V Knop,Andrea Telese,Ilaria Lenci,A. Andreoli,Stefan Zeuzem,Mario Angelico +11 more
TL;DR: All-oral sofosbuvir plus daclatasvirplus dac latasvir combination shows high virological efficacy in liver transplant recipients and does not interact with immunosuppressants.
Journal Article
C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection.
Enrico Scala,Gianpiero D'Offizi,R. Rosso,Ombretta Turriziani,Rosetta Ferrara,Anna Maria Mazzone,Guido Antonelli,Fernando Aiuti,Roberto Paganelli +8 more
TL;DR: It is postulate that all factors are needed to prevent HIV disease progression, and that viral suppression did not depend solely on C-C chemokines or IL-16.